Methotrexate Unknown Status Phase 2 Trials for Small Intestine Cancer / Disorders, Lymphoproliferative / Brain and Central Nervous System Tumors / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00287924High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
NCT00621036Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
NCT00974792Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
NCT00669812High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
NCT00503594Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
NCT00003261Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
NCT00002557Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides